FME.DE - Fresenius Medical Care AG & Co. KGaA

XETRA - XETRA Delayed Price. Currency in EUR

84.88

-0.16 (-0.19%)

At close: 5:35PM CEST

Stock chart is not supported by your current browser

Previous Close	85.04
Open	84.72
Bid	0.00 x 38700
Ask	0.00 x 105300
Day's Range	84.34 - 85.22
52 Week Range	76.42 - 93.82
Volume	573,371
Avg. Volume	645,300

Market Cap	26.012B
Beta	0.71
PE Ratio (TTM)	20.40
EPS (TTM)	4.16
Earnings Date	May 3, 2018
Forward Dividend & Yield	1.06 (1.28%)
Ex-Dividend Date	2018-05-18
1y Target Est	92.32

All

News

Press Releases

Reuters19 hours ago
Fresenius Medical sells U.S. Sound Inpatient for $2.15 billion
German dialysis specialist Fresenius Medical Care (FMEG.DE) is selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15 billion, it said on Saturday. The sale to an investment consortium led by private equity firm Summit Partners is expected to close in late 2018 and will bring a pretax book gain of about 800 million euros (£702 million) for the German company. Fresenius Medical Care, which says it is the world's largest provider of dialysis products and services, bought the stake in Sound Inpatient for about $600 million in 2014 as part of a drive to offer additional services linked to kidney dialysis.
Reuters20 hours ago
Fresenius Medical sells U.S. Sound Inpatient for $2.15 bln
German dialysis specialist Fresenius Medical Care is selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15 billion, it said on Saturday. The sale to an investment consortium led by private equity firm Summit Partners is expected to close in late 2018 and will bring a pretax book gain of about 800 million euros ($983 million) for the German company. Fresenius Medical Care, which says it is the world's largest provider of dialysis products and services, bought the stake in Sound Inpatient for about $600 million in 2014 as part of a drive to offer additional services linked to kidney dialysis.
Zacks2 days ago
IMF Raises Its Growth Forecast for Germany: 4 Top Picks
IMF's recent forecast on Germany's economic growth and encouraging comments from the country's finance ministry indicate its resilience to the recent economic cooldown.
Zacks4 days ago
Global Growth to Hit 7-Year High, Says IMF: 5 Picks
Projections for growth in the United States, Britain and Eurozone have experienced an upward revision.
Zacks12 days ago
Here's Why You Should Invest in Fresenius Medical Right Now
Fresenius Medical (FMS) receives a boost from solid guidance, higher geographical revenues and strategic acquisitions.
Simply Wall St.24 days ago
Can Fresenius Medical Care AG & Co KGaA (ETR:FME) Continue To Outperform Its Industry?
With an ROE of 14.36%, Fresenius Medical Care AG & Co KGaA (XTRA:FME) outpaced its own industry which delivered a less exciting 11.73% over the past year. Superficially, this looksRead More...
Zackslast month
3 Reasons Why You Should Invest in Fresenius Medical Now
Wide range of dialysis products, deliberate initiatives to gain market traction and solid international foothold are major catalysts for Fresenius Medical (FMS) at the moment.
Zackslast month
The Zacks Analyst Blog Highlights: Cerner, AmerisourceBergen, Fresenius and Olympus
The Zacks Analyst Blog Highlights: Cerner, AmerisourceBergen, Fresenius and Olympus
Simply Wall St.last month
Does Fresenius Medical Care AG & Co KGaA’s (ETR:FME) PE Ratio Signal A Buying Opportunity?
Fresenius Medical Care AG & Co KGaA (XTRA:FME) is trading with a trailing P/E of 19.6x, which is lower than the industry average of 21x. Although some investors may jumpRead More...
Zackslast month
3 Favorable Trends Dispelling Tax-Repeal Worries in MedTech
Here we analyze how the U.S. MedTech space is gearing up to counter the disquieting CBO projections regarding federal deficit.
Zackslast month
Top Analyst Reports for Royal Dutch Shell, Mastercard & Itau Unibanco
Top Analyst Reports for Royal Dutch Shell, Mastercard & Itau Unibanco
Zackslast month
Fresenius Medical (FMS) Q4 Earnings Beat, View Impressive
Higher sales of dialyzers, machines, peritoneal dialysis products, renal pharmaceuticals, bloodlines and products for acute care boost Fresenius Medical (FMS) in Q4.
Thomson Reuters StreetEvents2 months ago
Edited Transcript of FME.DE earnings conference call or presentation 27-Feb-18 2:30pm GMT
Q4 2017 Fresenius Medical Care AG & Co KGaA Earnings Call
ACCESSWIRE2 months ago
Fresenius Medical Care AG & Co. KGaA Published Form 20-F for the Fiscal Year 2017
BAD HOMBURG, GERMANY / ACCESSWIRE / February 27, 2018 / Fresenius Medical Care, the world's largest provider of dialysis products and services, announced that it has filed the annual report 2017 under ...
Motley Fool2 months ago
Here's Why Akorn, Inc. Stock Is Getting Thrashed Today
An issue with "data integrity" could derail a planned acquisition of the generic drugmaker.
Investor's Business Daily3 months ago
Fresenius Medical Shows Market Leadership With Jump To 82 RS Rating
Fresenius Medical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.
Benzinga4 months ago
Morgan Stanley Turns Bullish On Haemonetics, Raymond James Moves To The Sidelines
Haemonetics Corporation (NYSE: HAE ), a provider of blood and plasma services and supplies, may be benefiting from improved visibility on its transformation, according to Morgan Stanley. Raymond James ...
Investor's Business Daily4 months ago
Fresenius Medical Getting Closer To Key Technical Benchmark
Fresenius Medical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
Capital Cube4 months ago
Fresenius Medical Care AG & Co. KGaA :FME-DE: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
Categories: Yahoo FinanceGet free summary analysis Fresenius Medical Care AG & Co. KGaA reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Fresenius Medical Care AG & Co. KGaA – Fresenius SE & Co. KGaA, Baxter International Inc. and MEDICLIN AG (FRE-DE, BAX-CH and MED-DE) that ... Read more (Read more...)
Business Wire5 months ago
Fresenius Medical Care North America Sets Record in Surpassing its Kidney Walk Fundraising Goal
Fresenius Medical Care North America employees put on their walking shoes and raised nearly $300,000, the most amount ever raised by a National Team participating in Kidney Walk, the centerpiece fundraiser of the National Kidney Foundation .
Business Wire5 months ago
Fresenius Medical Care Achieves Improved Health Outcomes and Savings through National Medicare Demonstration Program
Fresenius Medical Care North America , the country’s leading provider of kidney care products and services, announced today the first performance year results from its End Stage Renal Disease Seamless Care Organizations .
Motley Fool5 months ago
NxStage Medical Prepares for Fresenius Merger
Find out how the dialysis specialist's business fared in the shadow of a buyout bid.